结直肠癌肝转移的治疗现状  

Current therapeutic options for colorectal liver metastases

作　　者：王盛[1] 喻春钊[1] 

机构地区：[1]江苏省南京医科大学第二附属医院普外科,210011

出　　处：《中华普通外科学文献（电子版）》2017年第1期51-55,共5页Chinese Archives of General Surgery(Electronic Edition)

基　　金：国家自然科学基金面上项目(30972910;81172269);江苏省自然科学基金资助项目(BK2011858);江苏省六大人才高峰基金资助项目(WSW-032)

摘　　要：肝脏是结直肠癌最常见的远处侵犯器官。目前肝切除是治疗结直肠癌肝转移(CLM)安全、有效且唯一有治愈可能的方法,且大于50%的患者术后可以获得5年生存。近年来,化疗、消融术、放射治疗等技术的不断完善,在一定程度上提高了国内外结直肠癌肝转移的诊疗水平。合理地联合应用这些疗法制定综合的治疗方案,对CLM患者的预后有着深远的影响。现就CLM的治疗现状作一综述。Colorectal cancer is one of the most common malignant tumors, with its distant metastasis mainly to the liver. Currently, hepatectomy is the only safe and effective measure to cure colorectal liver metastasis（CLM）, providing more than 50% 5-year-survival after the operation. In recent years, the diagnosis and treatment of CLM has been elevated with the improvement of chemotherapy, ablation, and radiotherapy. Comprehensive therapeutic schedule designed by appropriately integrating all the above-mentioned treatments exerts profound impact on the prognosis of CLM patients. This review attempts at summarizing the present status of CLM treatment.

关 键 词：结直肠肿瘤 肿瘤转移 肝切除术 综合疗法 

分 类 号：R735.34[医药卫生—肿瘤]